Trial
NCT02864316
Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Bristol-Myers Squibb
Condition
Solid Tumors Induced by Prior Radiation Exposure
Intervention
Nivolumab
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-28